Transcutaneous immunization with inactivated influenza virus induces protective immune responses

Vaccine

Volumn 24, Issue 35-36, 2006, Pages 6110-6119

  Skountzou, Ioanna ^a   Quan, Fu Shi ^a   Jacob, Joshy ^a   Compans, Richard W ^a   Kang, Sang Moo ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Influenza virus; Protective immune responses; Transcutaneous immunization

Indexed keywords

CHOLERA TOXIN; IMMUNOMODULATING AGENT; INACTIVATED VACCINE; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; OLEIC ACID; RETINOIC ACID; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEMAGGLUTINATION INHIBITION; IMMUNE RESPONSE; IMMUNIZATION; INFECTION; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN PENETRATION; VIRUS IMMUNITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CYTOKINES; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; IMMUNITY, MUCOSAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SPLEEN; VACCINES, INACTIVATED;

EID: 33746848966     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.014     Document Type: Article

References (48)

1. Romani N., Stingl G., Tschachler E., Witmer M.D., Steinman R.M., Shevach E.M., et al. The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells. J Exp Med 161 6 (1985) 1368-1383
2. Berry L.J., Hickey D.K., Skelding K.A., Bao S., Rendina A.M., Hansbro P.M., et al. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infect Immun 72 2 (2004) 1019-1028
3. Guerena-Burgueno F., Hall E.R., Taylor D.N., Cassels F.J., Scott D.A., Wolf M.K., et al. Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously. Infect Immun 70 4 (2002) 1874-1880
4. Godefroy S., Goestch L., Plotnicky-Gilquin H., Nguyen T.N., Schmitt D., Staquet M.J., et al. Immunization onto shaved skin with a bacterial enterotoxin adjuvant protects mice against respiratory syncytial virus (RSV). Vaccine 21 15 (2003) 1665-1671
5. El-Ghorr A.A., Williams R.M., Heap C., and Norval M. Transcutaneous immunisation with herpes simplex virus stimulates immunity in mice. FEMS Immunol Med Microbiol 29 4 (2000) 255-261
6. Glenn G.M., Scharton-Kersten T., Vassell R., Matyas G.R., and Alving C.R. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect Immun 67 3 (1999) 1100-1106
7. Seo N., Tokura Y., Nishijima T., Hashizume H., Furukawa F., and Takigawa M. Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc Natl Acad Sci USA 97 1 (2000) 371-376
8. Kahlon R., Hu Y., Orteu C.H., Kifayet A., Trudeau J.D., Tan R., et al. Optimization of epicutaneous immunization for the induction of CTL. Vaccine 21 21/22 (2003) 2890-2899
9. Hammond S.A., Walwender D., Alving C.R., and Glenn G.M. Transcutaneous immunization: T cell responses and boosting of existing immunity. Vaccine 19 17-19 (2001) 2701-2707
10. Baca-Estrada M.E., Ewen C., Mahony D., Babiuk L.A., Wilkie D., and Foldvari M. The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization. Immunology 107 1 (2002) 69-76
11. Parkinson E.K. Epidermal keratinocyte stem cells: their maintenance and regulation. Semin Cell Biol 3 6 (1992) 435-444
12. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
13. Norbury C.C., Malide D., Gibbs J.S., Bennink J.R., and Yewdell J.W. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol 3 3 (2002) 265-271
14. Cella M., Sallusto F., and Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9 1 (1997) 10-16
15. Scharton-Kersten T., Yu J., Vassell R., O'Hagan D., Alving C.R., and Glenn G.M. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect Immun 68 9 (2000) 5306-5313
16. Beignon A.S., Briand J.P., Muller S., and Partidos C.D. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge. Immunology 102 3 (2001) 344-351
17. Freytag L.C., and Clements J.D. Bacterial toxins as mucosal adjuvants. Curr Top Microbiol Immunol 236 (1999) 215-236
18. Kim D.D., Kim J.L., and Chien Y.W. Mutual hairless rat skin permeation-enhancing effect of ethanol/water system and oleic acid. J Pharm Sci 85 11 (1996) 1191-1195
19. Touitou E., Godin B., Karl Y., Bujanover S., and Becker Y. Oleic acid, a skin penetration enhancer, affects Langerhans cells and corneocytes. J Control Release 80 1-3 (2002) 1-7
20. Kligman A.M., Dogadkina D., and Lavker R.M. Effects of topical tretinoin on non-sun-exposed protected skin of the elderly. J Am Acad Dermatol 29 1 (1993) 25-33
21. Weiss J.S., Ellis C.N., Headington J.T., Tincoff T., Hamilton T.A., and Voorhees J.J. Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study. JAMA 259 4 (1988) 527-532
22. Fritsche J., Stonehouse T.J., Katz D.R., Andreesen R., and Kreutz M. Expression of retinoid receptors during human monocyte differentiation in vitro. Biochem Biophys Res Commun 270 1 (2000) 17-22
23. Mohty M., Morbelli S., Isnardon D., Sainty D., Arnoulet C., Gaugler B., et al. All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cells. Br J Haematol 122 5 (2003) 829-836
24. Ertesvag A., Engedal N., Naderi S., and Blomhoff H.K. Retinoic acid stimulates the cell cycle machinery in normal T cells: involvement of retinoic acid receptor-mediated IL-2 secretion. J Immunol 169 10 (2002) 5555-5563
25. Varani J., Zeigler M., Dame M.K., Kang S., Fisher G.J., Voorhees J.J., et al. Heparin-binding epidermal-growth-factor-like growth factor activation of keratinocyte ErbB receptors mediates epidermal hyperplasia, a prominent side-effect of retinoid therapy. J Invest Dermatol 117 6 (2001) 1335-1341
26. Compans R.W., Klenk H.D., Caliguiri L.A., and Choppin P.W. Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology 42 4 (1970) 880-889
27. Compans R.W. Hemagglutination-inhibition: rapid assay for neuraminic acid-containing viruses. J Virol 14 5 (1974) 1307-1309
28. Novak M., Moldoveanu Z., Schafer D.P., Mestecky J., and Compans R.W. Murine model for evaluation of protective immunity to influenza virus. Vaccine 11 1 (1993) 55-60
29. Sha Z., and Compans R.W. Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus. J Virol 74 11 (2000) 4999-5005
30. Glenn G.M., Scharton-Kersten T., Vassell R., Mallett C.P., Hale T.L., and Alving C.R. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J Immunol 161 7 (1998) 3211-3214
31. Kang S.M., and Compans R.W. Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus. J Virol 77 6 (2003) 3615-3623
32. Kang S.M., Guo L., Yao Q., Skountzou I., and Compans R.W. Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens. J Virol 78 18 (2004) 9624-9632
33. Sha Z., Kang S.M., and Compans R.W. Mucosal immunization of CD4(+) T cell-deficient mice with an inactivated virus induces IgG and IgA responses in serum and mucosal secretions. Virology 331 2 (2005) 387-395
34. Holmgren J., and Czerkinsky C. Mucosal immunity and vaccines. Nat Med 11 Suppl 4 (2005) S45-S53
35. Gockel C.M., Bao S., and Beagley K.W. Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract. Mol Immunol 37 9 (2000) 537-544
36. Belyakov I.M., Hammond S.A., Ahlers J.D., Glenn G.M., and Berzofsky J.A. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J Clin Invest 113 7 (2004) 998-1007
37. Deck R.R., DeWitt C.M., Donnelly J.J., Liu M.A., and Ulmer J.B. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine 15 1 (1997) 71-78
38. Laouini D., Alenius H., Bryce P., Oettgen H., Tsitsikov E., and Geha R.S. IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 112 7 (2003) 1058-1066
39. Kozlowski P.A., Cu-Uvin S., Neutra M.R., and Flanigan T.P. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 65 4 (1997) 1387-1394
40. Johansson E.L., Wassen L., Holmgren J., Jertborn M., and Rudin A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 69 12 (2001) 7481-7486
41. van der Ven I., and Sminia T. The development and structure of mouse nasal-associated lymphoid tissue: an immuno- and enzyme-histochemical study. Reg Immunol 5 2 (1993) 69-75
42. Spit B.J., Hendriksen E.G., Bruijntjes J.P., and Kuper C.F. Nasal lymphoid tissue in the rat. Cell Tissue Res 255 1 (1989) 193-198
43. Tilney N.L. Patterns of lymphatic drainage in the adult laboratory rat. J Anat 109 3 (1971) 369-383
44. Rudzik O., Clancy R.L., Perey D.Y., Bienenstock J., and Singal D.P. The distribution of a rabbit thymic antigen and membrane immunoglobulins in lymphoid tissue, with special reference to mucosal lymphocytes. J Immunol 114 1 Pt 1 (1975) 1-4
45. Gallichan W.S., Woolstencroft R.N., Guarasci T., McCluskie M.J., Davis H.L., and Rosenthal K.L. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J Immunol 166 5 (2001) 3451-3457
46. McCluskie M.J., and Davis H.L. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine 19 4/5 (2001) 413-422
47. Guebre-Xabier M., Hammond S.A., Epperson D.E., Yu J., Ellingsworth L., and Glenn G.M. Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells. J Virol 77 9 (2003) 5218-5225
48. Aste-Amezaga M., Ma X., Sartori A., and Trinchieri G. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol 160 12 (1998) 5936-5944